{"gene":"POLL","run_date":"2026-06-14T21:18:06+00:00","timeline":{"discoveries":[{"year":2000,"finding":"Murine Pol lambda (POLL) displays intrinsic DNA polymerase activity when overproduced in E. coli, assessed by in situ gel analysis. It contains all critical residues for DNA binding, nucleotide binding, selection, and catalysis conserved in family X polymerases, including residues required for deoxyribose phosphate lyase (dRPase) activity. Its BRCT domain (first 230 aa) has no counterpart in Pol beta.","method":"In situ gel DNA polymerase activity assay; sequence analysis; Northern blotting and immunostaining for localization","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro activity demonstrated in E. coli overexpression system, single lab, single method for enzymatic activity","pmids":["10966791"],"is_preprint":false},{"year":2002,"finding":"Human Pol lambda inserts nucleotides in a template-dependent manner and is processive on small gaps containing a 5'-phosphate group. It lacks proofreading activity and has ~37-fold higher affinity for dNTPs than Pol beta, consistent with function under low cellular dNTP levels. These properties support a role in base excision repair.","method":"Purification of recombinant human Pol lambda; biochemical polymerization and fidelity assays; nucleotide insertion kinetics","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution with purified protein, multiple orthogonal assays (processivity, fidelity, dNTP affinity), single lab","pmids":["11821417"],"is_preprint":false},{"year":2002,"finding":"Pol lambda has intrinsic template-directed DNA polymerase activity requiring Mn2+ or Mg2+ as metal cofactors. The proline-rich region acts as a suppressor domain for its polymerization activity (SDPA). PCNA directly interacts with Pol lambda through its Pol beta-like region in vitro, and this interaction negatively regulates Pol lambda activity.","method":"Recombinant protein expression in E. coli; truncation mutants; chimeric enzyme construction; in vitro PCNA interaction assay","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro pulldown and activity assay with deletion constructs, multiple methods, single lab","pmids":["12081642"],"is_preprint":false},{"year":2002,"finding":"Calf thymus-purified Pol lambda preferentially replicates damaged DNA and is aphidicolin-sensitive (unlike Pol beta). It has no detectable nuclease activity and is 6-fold more accurate than Pol beta in an M13mp2 forward mutation assay.","method":"Protein purification from calf thymus (5 chromatographic steps); polymerase activity assay on damaged and undamaged DNA; M13mp2 forward mutation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — biochemical characterization with purified native protein, single lab, single set of experiments","pmids":["11886860"],"is_preprint":false},{"year":2004,"finding":"Crystal structure of human Pol lambda catalytic core in complex with a two-nucleotide gap DNA at 2.1 Å reveals limited contacts with template strand at the active site, a shift in DNA position reminiscent of a deletion intermediate, and the ability to adopt a closed conformation even without dNTP binding.","method":"X-ray crystallography (2.1 Å resolution); structural comparison with Pol beta ternary complex","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with functional implications, multiple structural comparisons, replicated by subsequent structural studies","pmids":["14992725"],"is_preprint":false},{"year":2005,"finding":"Pol lambda contributes to base excision repair (BER) as a backup to Pol beta. Using extracts from pol beta-/- and pol lambda-/- mouse embryonic fibroblasts combined with neutralizing antibodies, pol lambda antibody strongly reduced in vitro BER in pol beta-/- extracts, demonstrating pol lambda can substitute for pol beta in BER.","method":"Cell extract BER assay; pol lambda-/- and pol beta-/- mouse embryonic fibroblasts; neutralizing antibodies against pol lambda and pol beta","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic null cell lines combined with antibody neutralization, multiple genotypes tested, functional BER readout","pmids":["15749700"],"is_preprint":false},{"year":2005,"finding":"Pol lambda directly binds PCNA through a confined C-terminal region (residues 518–537), distinct from the canonical PIM motif. In vivo, Pol lambda co-immunoprecipitates with PCNA and EGFP-tagged Pol lambda co-localizes with PCNA as nuclear spots. PCNA binding suppresses the distributive nucleotidyltransferase activity of Pol lambda.","method":"Pull-down assay with deletion mutants; competitive peptide assay; co-immunoprecipitation; fluorescence microscopy (EGFP co-localization)","journal":"Genes to cells","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal in vitro pulldown and in vivo co-IP, localization by fluorescence microscopy, functional consequence (activity suppression), multiple orthogonal methods","pmids":["15966901"],"is_preprint":false},{"year":2006,"finding":"Pol lambda extends mismatched primer termini with ~10^-2 efficiency relative to matched pairs; efficiency is ~260-fold higher on 1-nt gapped molecules with 5'-phosphate versus open template-primer. A 2.4 Å crystal structure of Pol lambda with a dG:dGMP mismatch at the primer terminus shows Pol lambda cannot distinguish matched from mismatched termini during DNA binding, explaining its mismatch extension capacity relevant to NHEJ.","method":"In vitro mismatch extension kinetics; X-ray crystallography (2.4 Å) of mismatch-containing complex","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical kinetics combined with crystal structure, mechanistic explanation validated structurally, single lab","pmids":["16807316"],"is_preprint":false},{"year":2007,"finding":"Crystal structures of Pol lambda at 1.9 Å (with non-hydrolyzable dUpnpp and Na+ at metal A site) and 2.0 Å (after soaking in MnCl2) reveal that Mn2+ occupying the metal A site induces a C3'-endo ribose conformation that positions the 3'-OH in-line with the alpha-phosphate, supporting a two-metal-ion catalytic mechanism. Catalysis in the crystal was directly observed upon MnCl2 soaking.","method":"X-ray crystallography (1.9 Å and 2.0 Å structures); crystal soaking experiments; structural comparison of pre- and post-catalytic states","journal":"DNA repair","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple high-resolution crystal structures including pre- and post-catalytic states, catalysis observed in crystal, mechanistic detail directly established","pmids":["17475573"],"is_preprint":false},{"year":2007,"finding":"Pol lambda efficiently uses 8-oxoguanine (8-oxoG) as a template, inserting either dAMP or dCMP opposite it, but strongly discriminates against extension of the mutagenic 8-oxoG:dAMP pair while readily extending the non-mutagenic 8-oxoG:dCMP pair. Similar non-mutagenic extension was shown for O6-methylguanine.","method":"In vitro primer extension assay; kinetic analysis with purified human Pol lambda on 8-oxoG and m6G templates","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro biochemical assay with purified protein, single lab, no structural validation in this study","pmids":["17686665"],"is_preprint":false},{"year":2008,"finding":"CDK2 phosphorylates Pol lambda in vitro. Phosphorylation of Thr553 is important for Pol lambda stability; a phosphorylation-defective T553 mutant is targeted for proteasomal degradation via ubiquitination. Pol lambda is stabilized during late S and G2 phases of the cell cycle, mimicking CDK2/cyclin A activity.","method":"In vitro kinase assay (CDK2); phosphorylation-defective mutant analysis; cell cycle synchronization; proteasome inhibitor experiments; Western blotting","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay plus in vivo mutant analysis and cell cycle experiments, multiple orthogonal methods, single lab","pmids":["18688254"],"is_preprint":false},{"year":2008,"finding":"RPA stimulates translesion DNA synthesis by Pol lambda in its globular conformation (not extended). This stimulation requires the p70N and p32C domains of RPA for protein-protein interactions.","method":"In vitro TLS assay with purified Pol lambda, RPA, and mutant hABCD RPA lacking protein-protein interaction domains; primer-template substrates with 8-oxoguanine","journal":"Biochemistry. Biokhimiia","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vitro reconstitution with domain-deletion mutants of RPA, single lab, single method","pmids":["18976222"],"is_preprint":false},{"year":2009,"finding":"MUTYH glycosylase and Pol lambda cooperate in a complete 8-oxo-G repair pathway. MUTYH, Pol lambda, PCNA, FEN1, and DNA ligases I and III are specifically recruited from human cell extracts to A:8-oxo-G DNA. The full repair pathway for A:8-oxo-G mispairs was reconstituted in vitro with purified MUTYH, Pol lambda, FEN1, and DNA ligase I.","method":"Immunofluorescence in ROS-exposed cells; in vitro DNA pulldown from cell extracts; full pathway reconstitution with purified proteins","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — full pathway reconstitution with purified proteins plus cell-based immunofluorescence validation, multiple orthogonal methods","pmids":["19820168"],"is_preprint":false},{"year":2010,"finding":"Loop 1 of Pol lambda modulates fidelity by controlling dNTP-induced movements of the template strand and primer-terminal 3'-OH during the inactive-to-active conformation transition. Replacing 9 loop 1 residues with those from Pol beta did not affect catalytic efficiency for correct incorporation or NHEJ participation but significantly reduced accuracy in three biochemical fidelity assays.","method":"X-ray crystallography of loop 1 mutant (binary and ternary complexes); in vitro NHEJ assay; multiple fidelity assays; structural comparison","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures of mutant enzyme plus multiple biochemical fidelity assays, mechanistic model directly supported by structural data","pmids":["20435673"],"is_preprint":false},{"year":2010,"finding":"Crystal structures show AraC and gemcitabine (dFdC) can bind within the nascent base pair binding pocket of Pol lambda. Pol lambda efficiently incorporates AraCTP but not dFdCTP, with the conformation of dFdCTP ribose being significantly different from normal dCTP.","method":"X-ray crystallography of Pol lambda bound to AraC or dFdC opposite template dG in gapped DNA; kinetic incorporation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures combined with biochemical incorporation assays, mechanistic explanation for differential incorporation","pmids":["20348107"],"is_preprint":false},{"year":2011,"finding":"Pol lambda undergoes ubiquitylation as a post-translational modification that regulates its stability and possibly subcellular localization during the cell cycle.","method":"Review summarizing experimental evidence for Pol lambda ubiquitylation (referenced from primary experiments)","journal":"FEBS letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — review paper summarizing prior findings without new primary data described in abstract","pmids":["21486570"],"is_preprint":false},{"year":2012,"finding":"Pol lambda can perform gap-filling BER bypass of AP sites located at positions adjacent to (+)-cis-BPDE-dG adducts (but not trans-isomers), inserting correct dCTP. AP sites directly opposite cis-BP adducts can be repaired by Pol lambda but not Pol beta.","method":"In vitro primer extension and gap-filling assays with defined AP-site-containing oligonucleotide substrates bearing cis- or trans-BPDE-dG adducts; comparison of Pol lambda vs Pol beta","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro biochemical assay with purified proteins and defined substrates, single lab, single method","pmids":["22317757"],"is_preprint":false},{"year":2013,"finding":"Pol lambda is irreversibly inactivated by oxidized abasic lesions DOB and pC4-AP via covalent modification of active-site Lys324 (and potentially Lys312) in its lyase active site. Lyase inactivation also prevents polymerization. DOB inactivates Pol lambda ~3-fold less efficiently than Pol beta.","method":"Single-turnover kinetics; mass spectrometry of GluC-digested inactivated Pol lambda; defined lesion-containing DNA substrates","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — kinetics plus mass spectrometric identification of modified residues, direct mechanistic identification of inactivation sites","pmids":["23330920"],"is_preprint":false},{"year":2014,"finding":"The BRCT domain of Pol lambda enhances abasic site bypass efficiency (~1.6-fold). The BRCT and proline-rich domains cooperatively promote -2 frameshift mutations through homology-driven primer realignment and increase -1 frameshift frequency during 8-oxodG bypass.","method":"Primer extension assays; high-throughput short oligonucleotide sequencing assay (HT-SOSA); N-terminal deletion constructs of Pol lambda","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple complementary biochemical assays with deletion constructs, two orthogonal sequencing approaches, single lab","pmids":["25108835"],"is_preprint":false},{"year":2016,"finding":"Seven crystal structures and pre-steady-state kinetics characterize 8-oxo-dG bypass by Pol lambda. Pol lambda accommodates 8-oxo-dG in both anti and syn conformations; discrimination against the pro-mutagenic syn-conformation occurs at the extension step. A specific residue acts as a kinetic switch shunting repair toward long-patch BER upon correct dCMP insertion.","method":"X-ray crystallography (7 novel structures); pre-steady-state kinetics; mutagenesis to identify fidelity-determining residue","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple crystal structures combined with kinetics and mutagenesis, mechanistic detail fully characterized in single rigorous study","pmids":["27481934"],"is_preprint":false},{"year":2016,"finding":"Pol lambda apo-form exists in a closed conformation with a preformed MgdNTP binding pocket; a hydrophobic core (Leu431, Ile492, Tyr505/Phe506) attenuates MgdNTP prebinding to maintain medium fidelity. L431A mutation enhances MgdNTP prebinding and lowers fidelity. MgdNTP prebinding can stabilize mismatched and destabilize matched ternary complexes.","method":"X-ray crystallography (12 crystal structures); pre-steady-state kinetics; site-directed mutagenesis (L431A)","journal":"Journal of the American Chemical Society","confidence":"High","confidence_rationale":"Tier 1 / Strong — 12 crystal structures combined with kinetics and mutagenesis, multiple orthogonal methods in single study","pmids":["26836966"],"is_preprint":false},{"year":2017,"finding":"The BRCT and proline/serine-rich (PSR) domains of Pol lambda impede its nuclear localization; the nuclear localization signal (NLS) is required to overcome this impediment. DNA damage induces Pol lambda recruitment to chromatin, controlled by the BRCT and PSR domains. Both domains are required for Pol lambda-mediated tolerance of oxidative but not methylation DNA damage.","method":"Western blot; fluorescence microscopy; cell survival assays; deletion constructs of BRCT, PSR, and NLS domains","journal":"Chemical research in toxicology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell-based methods (imaging, fractionation, survival) with domain-deletion constructs, functional and localization readouts, single lab","pmids":["28380295"],"is_preprint":false},{"year":2018,"finding":"PAXX, XLF, and XRCC4 share the ability to interact with Pol lambda, stimulate its activity, and are required for recruitment of Pol lambda to laser-induced DNA damage sites. Stimulation requires direct interaction between the SP/8 kDa domain of Pol lambda and the N-terminal head domains of XRCC4 paralogs to facilitate recognition of 5' end of substrate gaps. PAXX and XLF collaborate with Pol lambda for joining of incompatible DNA ends and are redundant in supporting Pol lambda function in vivo.","method":"Interactome analysis; direct interaction assays; Pol lambda activity stimulation assays; laser micro-irradiation and recruitment assays; in vivo NHEJ assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (interactome, direct binding, activity stimulation, live-cell recruitment, in vivo NHEJ), results replicated across three paralogs","pmids":["30250067"],"is_preprint":false},{"year":2020,"finding":"Pol lambda is SUMOylated in vitro and in vivo, with Lys27 being the primary SUMO conjugation site. SUMOylation is mediated by the E3 ligase RanBP2 at the nuclear pore complex. This modification promotes Pol lambda nuclear entry, which is required for its recruitment to DNA lesions and is stimulated by DNA damage.","method":"In vitro SUMOylation assay; in vivo SUMOylation (co-IP); site-directed mutagenesis (K27); nuclear fractionation; immunofluorescence and damage recruitment assays","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro and in vivo SUMOylation with mutagenesis identifying modification site, identification of E3 ligase, functional consequence (nuclear entry/recruitment) with multiple methods","pmids":["32224012"],"is_preprint":false},{"year":2021,"finding":"Pol lambda promotes error-free replication through N1-methyl-deoxyadenosine (1-MeA) by inserting the correct nucleotide T opposite 1-MeA, likely via Hoogsteen base pairing with 1-MeA in a syn conformation. Pol lambda acts as the insertion polymerase in a Pol lambda/Pol zeta-dependent TLS pathway for 1-MeA bypass.","method":"Biochemical TLS assay with purified Pol lambda; genetic analysis in human cells (siRNA knockdown); epistasis with Pol zeta","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical insertion assay with purified polymerase combined with genetic epistasis in human cells, single lab","pmids":["34119520"],"is_preprint":false},{"year":2021,"finding":"Pol lambda promotes annealing of G-rich telomeric repeats to complementary strands and can prime DNA synthesis on these substrates. POT1/TPP1 heterodimer stimulates this activity, while TERRA RNA and RPA negatively regulate it. Pol lambda associates with telomeres and co-localizes with TPP1 in cells, and its silencing represses ALT activity and induces telomeric stress.","method":"Annealing and primer extension assays with purified proteins; co-immunoprecipitation/ChIP for telomere association; immunofluorescence co-localization; siRNA knockdown with ALT activity readout","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro biochemical reconstitution plus cell-based co-localization and knockdown, multiple methods, single lab","pmids":["33673424"],"is_preprint":false},{"year":2023,"finding":"The non-catalytic N-terminal region of Pol lambda (BRCT and proline-rich domains) suppresses both its polymerase activity and its interactions with DNA and with PARP1. RPA interaction with Pol lambda is also modulated by these non-catalytic domains.","method":"In vitro polymerase activity assays; protein-protein interaction assays (Pol lambda with PARP1 and RPA); N-terminal deletion constructs","journal":"Doklady. Biochemistry and biophysics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — in vitro assays with deletion constructs, single lab, single paper, limited detail in abstract","pmids":["38093124"],"is_preprint":false},{"year":2024,"finding":"A Pol lambda loop 1 variant (PolλKGET) retains canonical Pol lambda activity on paired DNA ends but acquires the ability to synthesize from unpaired primer termini—activity normally unique to Pol mu. The Loop1 amino acid sequence is essential for this gained activity during NHEJ despite making no direct contact with DNA substrate.","method":"In vitro NHEJ assay; primer extension on paired and unpaired substrates; structural prediction","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical NHEJ and extension assays with defined mutant, multiple substrate types tested, single lab","pmids":["38428373"],"is_preprint":false},{"year":2024,"finding":"XRCC1 stimulates the gap-filling activity of Pol lambda under conditions of microphase separation. XRCC1 forms protein-rich microphases with DNA, and Pol lambda, XRCC1, and gapped DNA co-localize within these microphases. Stimulation occurs at micromolar XRCC1 concentrations and requires both protein-protein interaction and microphase separation conditions.","method":"In vitro gap-filling assay; dynamic light scattering; fluorescence microscopy for co-localization in microphases; binding affinity measurement for XRCC1-Pol lambda complex","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro reconstitution plus biophysical characterization (DLS, fluorescence microscopy), multiple orthogonal methods, single lab","pmids":["39000034"],"is_preprint":false},{"year":2026,"finding":"Pol lambda possesses an autoinhibitory intramolecular interaction between its N-terminal BRCT domain and C-terminal catalytic domain. Ku binding to the KBM within the BRCT domain relieves this autoinhibition, increasing both Pol lambda binding rate to primer-template DNA and nucleotide incorporation rate. Single-molecule assays demonstrate Ku stimulates Pol lambda polymerase activity at DSBs within the short-range synaptic complex during NHEJ.","method":"Structural prediction; biochemical activity assays; single-molecule approaches; KBM mutagenesis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — structural prediction validated by biochemical assays and single-molecule experiments with mutagenesis, multiple orthogonal methods establishing autoinhibition mechanism","pmids":["41700088"],"is_preprint":false}],"current_model":"DNA polymerase lambda (POLL) is a family X DNA repair polymerase that fills short gaps during base excision repair (BER) and non-homologous end joining (NHEJ) of double-strand breaks via a two-metal-ion phosphoryl transfer mechanism; its activity is regulated by an autoinhibitory BRCT-catalytic domain interaction relieved by Ku binding, by CDK2-mediated phosphorylation of Thr553 (protecting it from ubiquitin-proteasomal degradation), by RanBP2-mediated SUMOylation at Lys27 (promoting nuclear import), by direct interaction with PCNA (via residues 518–537, suppressing distributive activity), and by stimulation from XRCC4 paralogs (PAXX, XLF, XRCC4) through their head domains binding the SP/8 kDa domain of Pol lambda; its medium fidelity is mechanistically enforced by a hydrophobic core attenuating MgdNTP prebinding and by Loop 1 controlling template strand positioning, while its unique BRCT and proline-rich N-terminal domains modulate nuclear localization, damage recruitment, primer realignment, and selective tolerance of oxidative DNA damage."},"narrative":{"mechanistic_narrative":"DNA polymerase lambda (POLL) is a family X DNA repair polymerase that fills short DNA gaps during base excision repair (BER) and non-homologous end joining (NHEJ), using a two-metal-ion phosphoryl transfer mechanism in which Mn2+/Mg2+ at the metal A site positions the primer 3'-OH in-line with the alpha-phosphate for catalysis [PMID:17475573]. It is template-dependent, lacks proofreading, is processive on small 5'-phosphate-containing gaps, and has high dNTP affinity consistent with function at low cellular dNTP levels [PMID:11821417]. Pol lambda serves as a backup to Pol beta in BER, substituting for it in cell-extract repair [PMID:15749700], and it cooperates with the MUTYH glycosylase, PCNA, FEN1, and DNA ligases in a reconstituted pathway that repairs A:8-oxo-G mispairs [PMID:19820168]. Its medium fidelity is mechanistically enforced by a closed apo-conformation with a preformed MgdNTP pocket whose hydrophobic core attenuates MgdNTP prebinding [PMID:26836966] and by Loop 1, which controls dNTP-induced template-strand and primer-terminus movements [PMID:20435673]; structural studies further show it accommodates 8-oxo-dG in anti and syn forms and discriminates against the mutagenic pairing at the extension step [PMID:27481934]. In NHEJ, Pol lambda extends mismatched and partially paired ends [PMID:16807316], is stimulated and recruited to damage by the XRCC4 paralogs PAXX, XLF, and XRCC4 binding its SP/8 kDa domain [PMID:30250067], and its catalytic activity is relieved from an autoinhibitory BRCT–catalytic domain interaction by Ku binding within the short-range synaptic complex [PMID:41700088]. Its non-catalytic BRCT and proline-rich N-terminal domains suppress polymerase activity and DNA/partner interactions, govern nuclear localization and chromatin recruitment, and confer selective tolerance of oxidative damage [PMID:28380295, PMID:38093124]. Pol lambda activity is post-translationally tuned by CDK2 phosphorylation of Thr553, which protects it from ubiquitin-proteasomal degradation across the cell cycle [PMID:18688254], and by RanBP2-mediated SUMOylation at Lys27, which promotes nuclear entry and damage recruitment [PMID:32224012].","teleology":[{"year":2000,"claim":"Established that POLL encodes an intrinsically active DNA polymerase of the family X repair class, distinguished from Pol beta by an additional BRCT domain.","evidence":"In situ gel polymerase activity assay of murine Pol lambda overexpressed in E. coli with sequence analysis","pmids":["10966791"],"confidence":"Medium","gaps":["Activity shown only in an overexpression system","No defined repair substrate or cellular pathway assigned","dRPase activity inferred from conserved residues, not measured"]},{"year":2002,"claim":"Defined the enzymatic profile pointing to BER: template-dependent, processive on 5'-phosphate gaps, no proofreading, and high dNTP affinity, while identifying PCNA as a negative regulator acting through the proline-rich suppressor domain.","evidence":"Biochemical assays with purified recombinant human Pol lambda; truncation mutants and in vitro PCNA interaction; calf-thymus native protein characterization","pmids":["11821417","12081642","11886860"],"confidence":"High","gaps":["BER role inferred from biochemistry, not yet genetically demonstrated","Physiological relevance of PCNA suppression untested in cells","Damaged-template preference not mechanistically explained"]},{"year":2004,"claim":"Provided the structural basis for gap-filling, showing limited template contacts and a DNA shift resembling a deletion intermediate, foreshadowing frameshift propensity.","evidence":"2.1 Å crystal structure of the catalytic core on two-nucleotide gap DNA, compared to Pol beta","pmids":["14992725"],"confidence":"High","gaps":["Catalytic chemistry not yet captured","Role of N-terminal domains not addressed by core structure","Functional consequence of deletion-like intermediate not tested"]},{"year":2005,"claim":"Demonstrated genetically that Pol lambda substitutes for Pol beta in BER and mapped a non-canonical PCNA-binding region controlling distributive activity.","evidence":"Cell-extract BER assays in pol beta-/- and pol lambda-/- MEFs with neutralizing antibodies; reciprocal pulldown, co-IP, and EGFP co-localization for PCNA","pmids":["15749700","15966901"],"confidence":"High","gaps":["Relative in vivo contribution of Pol lambda vs Pol beta unquantified","Conditions selecting Pol lambda over Pol beta unclear","PCNA recruitment dynamics at lesions not defined"]},{"year":2007,"claim":"Resolved the two-metal-ion catalytic mechanism and connected Pol lambda to oxidative-damage processing by showing non-mutagenic extension of 8-oxoG:dCMP.","evidence":"1.9/2.0 Å crystal structures with catalysis observed upon MnCl2 soaking; primer-extension kinetics on 8-oxoG and m6G templates","pmids":["17475573","17686665"],"confidence":"High","gaps":["Structural basis of syn/anti 8-oxoG discrimination not yet resolved","In vivo relevance of damage-tolerant extension untested","Metal selectivity (Mn vs Mg) physiology unaddressed"]},{"year":2008,"claim":"Identified cell-cycle-coupled stability control, showing CDK2 phosphorylation of Thr553 protects Pol lambda from ubiquitin-proteasomal degradation, and partner-mediated TLS stimulation by RPA.","evidence":"In vitro CDK2 kinase assay, phospho-defective mutant, cell-cycle synchronization and proteasome inhibition; in vitro TLS reconstitution with RPA domain-deletion mutants","pmids":["18688254","18976222"],"confidence":"High","gaps":["E3 ligase targeting Pol lambda not identified","Functional output of S/G2 stabilization not linked to a repair event","RPA stimulation mechanism not structurally defined"]},{"year":2009,"claim":"Placed Pol lambda within a complete reconstituted pathway for repair of A:8-oxo-G mispairs, defining its functional partners in oxidative-damage repair.","evidence":"Immunofluorescence in ROS-exposed cells, DNA pulldown from extracts, and full reconstitution with purified MUTYH, Pol lambda, FEN1, and DNA ligase I","pmids":["19820168"],"confidence":"High","gaps":["Order and regulation of factor handoff not defined","Direct Pol lambda–MUTYH interaction surface unmapped","Contribution relative to other polymerases in vivo unquantified"]},{"year":2010,"claim":"Defined structural determinants of fidelity (Loop 1 controlling template/primer movement) and the active-site recognition of nucleoside-analog drugs.","evidence":"Crystal structures of loop 1 mutant with NHEJ and fidelity assays; structures of AraC/gemcitabine bound in the nascent base-pair pocket with kinetics","pmids":["20435673","20348107"],"confidence":"High","gaps":["Loop 1 contribution to in vivo mutagenesis not measured","Therapeutic relevance of analog incorporation untested in cells","Interplay of Loop 1 with N-terminal domains unaddressed"]},{"year":2013,"claim":"Established a mechanism of irreversible lyase-driven self-inactivation by oxidized abasic lesions through covalent modification of active-site lysines.","evidence":"Single-turnover kinetics and mass spectrometry of GluC-digested inactivated Pol lambda with defined DOB/pC4-AP substrates","pmids":["23330920"],"confidence":"High","gaps":["Cellular consequences of this suicide inactivation not demonstrated","Whether inactivation occurs at physiological lesion levels unknown","Relationship to Pol beta inactivation in shared lesions not resolved"]},{"year":2014,"claim":"Assigned functions to the non-catalytic N-terminal domains, showing BRCT and proline-rich regions drive homology-mediated primer realignment and frameshift mutagenesis.","evidence":"Primer extension and HT-SOSA sequencing with N-terminal deletion constructs on abasic and 8-oxodG substrates","pmids":["25108835"],"confidence":"Medium","gaps":["In vivo frameshift signature not established","Structural basis of realignment by N-terminal domains unresolved","Single-lab biochemical observation"]},{"year":2016,"claim":"Provided a unified structural-kinetic model of medium fidelity, defining 8-oxoG handling at the extension step and a hydrophobic core that attenuates MgdNTP prebinding.","evidence":"Multiple crystal structures (7 and 12) with pre-steady-state kinetics and mutagenesis (L431A, kinetic-switch residue)","pmids":["27481934","26836966"],"confidence":"High","gaps":["Cellular fidelity consequences of core mutations untested","Long-patch vs short-patch BER routing in vivo unconfirmed","Generalizability of prebinding model to all substrates unclear"]},{"year":2017,"claim":"Showed that the BRCT and proline/serine-rich domains restrain nuclear import and govern damage-induced chromatin recruitment, conferring selective tolerance of oxidative damage.","evidence":"Fluorescence microscopy, fractionation, and survival assays with BRCT/PSR/NLS deletion constructs","pmids":["28380295"],"confidence":"Medium","gaps":["Molecular signal triggering recruitment unidentified","Mechanism distinguishing oxidative vs methylation tolerance unclear","Single-lab cell-based study"]},{"year":2018,"claim":"Identified the XRCC4-paralog interface, showing PAXX, XLF, and XRCC4 bind the SP/8 kDa domain to stimulate activity and recruit Pol lambda to DSBs for joining of incompatible ends.","evidence":"Interactome, direct binding, activity stimulation, laser micro-irradiation recruitment, and in vivo NHEJ assays across three paralogs","pmids":["30250067"],"confidence":"High","gaps":["Structural detail of the SP/8 kDa–head domain interface not solved","Hierarchy among the three paralogs in vivo not fully resolved","Integration with core NHEJ machinery timing unclear"]},{"year":2020,"claim":"Defined a SUMO-dependent nuclear import route, with RanBP2 SUMOylating Lys27 at the nuclear pore to enable damage recruitment.","evidence":"In vitro and in vivo SUMOylation, K27 mutagenesis, nuclear fractionation, and damage-recruitment imaging","pmids":["32224012"],"confidence":"High","gaps":["Interplay between SUMOylation and BRCT/PSR import restraint unresolved","Whether SUMOylation is damage-inducible at the modification step unclear","deSUMOylation/reversal not characterized"]},{"year":2021,"claim":"Extended Pol lambda's repertoire to error-free TLS of 1-MeA and to telomere maintenance, including a role in ALT activity.","evidence":"Biochemical TLS with epistasis to Pol zeta in human cells; annealing/extension assays with POT1/TPP1, TERRA, RPA regulation and telomere co-localization/knockdown","pmids":["34119520","33673424"],"confidence":"Medium","gaps":["In vivo significance of telomeric role beyond ALT cells unknown","Structural basis of 1-MeA Hoogsteen bypass not solved","Single-lab observations for each role"]},{"year":2024,"claim":"Showed that microenvironment and Loop 1 sequence tune Pol lambda's end-joining behavior: XRCC1 microphase separation stimulates gap filling, and a Loop 1 variant gains Pol mu-like unpaired-primer synthesis.","evidence":"In vitro gap-filling with DLS and microscopy of XRCC1 microphases; NHEJ and paired/unpaired primer-extension assays with the PolλKGET Loop 1 variant","pmids":["39000034","38428373"],"confidence":"Medium","gaps":["Physiological occurrence of microphase separation unverified","How Loop 1 confers activity without DNA contact unexplained","In vivo relevance of engineered Loop 1 variant unknown"]},{"year":2026,"claim":"Resolved the principal autoregulatory switch, demonstrating an intramolecular BRCT–catalytic autoinhibition relieved by Ku binding to activate Pol lambda within the NHEJ synaptic complex.","evidence":"Structural prediction with biochemical activity and single-molecule assays and KBM mutagenesis","pmids":["41700088"],"confidence":"High","gaps":["High-resolution structure of the autoinhibited state not determined","Coordination of Ku relief with XRCC4-paralog and PTM regulation unresolved","Whether the same switch operates in BER unclear"]},{"year":null,"claim":"How the multiple regulatory layers—N-terminal autoinhibition, Ku/XRCC4-paralog stimulation, PCNA/RPA/PARP1/XRCC1 modulation, and CDK2/SUMO post-translational control—are integrated to select Pol lambda for BER versus NHEJ versus telomere maintenance in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified in vivo model coordinating the regulatory inputs","Quantitative pathway partitioning of Pol lambda not established","No disease association mapped within the available corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,1,4,8]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,8,19]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,7,20]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,17]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,21,23]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[21]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[5,12,22,29]}],"complexes":["NHEJ short-range synaptic complex"],"partners":["PCNA","XRCC4","XLF","PAXX","KU","RPA","XRCC1","MUTYH"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UGP5","full_name":"DNA polymerase lambda","aliases":["DNA polymerase beta-2","Pol beta2","DNA polymerase kappa"],"length_aa":575,"mass_kda":63.5,"function":"DNA polymerase that functions in several pathways of DNA repair (PubMed:11457865, PubMed:19806195, PubMed:20693240, PubMed:30250067). Involved in base excision repair (BER) responsible for repair of lesions that give rise to abasic (AP) sites in DNA (PubMed:11457865, PubMed:19806195). Also contributes to DNA double-strand break repair by non-homologous end joining and homologous recombination (PubMed:19806195, PubMed:20693240, PubMed:30250067). Has both template-dependent and template-independent (terminal transferase) DNA polymerase activities (PubMed:10887191, PubMed:10982892, PubMed:12809503, PubMed:14627824, PubMed:15537631, PubMed:19806195). Also has a 5'-deoxyribose-5-phosphate lyase (dRP lyase) activity (PubMed:11457865, PubMed:19806195)","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q9UGP5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POLL","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/POLL","total_profiled":1310},"omim":[{"mim_id":"620442","title":"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 5; BROVCA5","url":"https://www.omim.org/entry/620442"},{"mim_id":"619545","title":"HYPOPLASTIC FEMURS AND PELVIS; HYPOFP","url":"https://www.omim.org/entry/619545"},{"mim_id":"619424","title":"MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY; MFM12","url":"https://www.omim.org/entry/619424"},{"mim_id":"618266","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12","url":"https://www.omim.org/entry/618266"},{"mim_id":"617964","title":"LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16","url":"https://www.omim.org/entry/617964"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLL"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9UGP5","domains":[{"cath_id":"3.40.50.10190","chopping":"46-138","consensus_level":"high","plddt":85.4545,"start":46,"end":138},{"cath_id":"1.10.150.110","chopping":"249-328","consensus_level":"medium","plddt":92.4732,"start":249,"end":328},{"cath_id":"1.10.150.20","chopping":"331-385","consensus_level":"medium","plddt":97.1871,"start":331,"end":385},{"cath_id":"3.30.460.10","chopping":"388-495","consensus_level":"high","plddt":94.3629,"start":388,"end":495},{"cath_id":"3.30.210.10","chopping":"509-573","consensus_level":"high","plddt":95.0351,"start":509,"end":573}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UGP5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UGP5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UGP5-F1-predicted_aligned_error_v6.png","plddt_mean":80.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLL","jax_strain_url":"https://www.jax.org/strain/search?query=POLL"},"sequence":{"accession":"Q9UGP5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UGP5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UGP5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UGP5"}},"corpus_meta":[{"pmid":"10966791","id":"PMC_10966791","title":"DNA polymerase lambda (Pol lambda), a novel eukaryotic DNA polymerase with a potential role in meiosis.","date":"2000","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10966791","citation_count":239,"is_preprint":false},{"pmid":"11821417","id":"PMC_11821417","title":"DNA polymerase lambda, a novel DNA repair enzyme in human cells.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11821417","citation_count":169,"is_preprint":false},{"pmid":"15749700","id":"PMC_15749700","title":"DNA polymerase lambda mediates a back-up base excision repair activity in extracts of mouse embryonic fibroblasts.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15749700","citation_count":132,"is_preprint":false},{"pmid":"14992725","id":"PMC_14992725","title":"A structural solution for the DNA polymerase lambda-dependent repair of DNA gaps with minimal homology.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/14992725","citation_count":118,"is_preprint":false},{"pmid":"12081642","id":"PMC_12081642","title":"Over-expression of human DNA polymerase lambda in E. coli and characterization of the recombinant enzyme.","date":"2002","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/12081642","citation_count":104,"is_preprint":false},{"pmid":"19820168","id":"PMC_19820168","title":"An 8-oxo-guanine repair pathway coordinated by MUTYH glycosylase and DNA polymerase lambda.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19820168","citation_count":103,"is_preprint":false},{"pmid":"11886860","id":"PMC_11886860","title":"DNA polymerase lambda from calf thymus preferentially replicates damaged DNA.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11886860","citation_count":63,"is_preprint":false},{"pmid":"17475573","id":"PMC_17475573","title":"Role of the catalytic metal during polymerization by DNA polymerase lambda.","date":"2007","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/17475573","citation_count":60,"is_preprint":false},{"pmid":"24716527","id":"PMC_24716527","title":"Structure-function studies of DNA polymerase λ.","date":"2014","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24716527","citation_count":57,"is_preprint":false},{"pmid":"16213194","id":"PMC_16213194","title":"Structure-function studies of DNA polymerase lambda.","date":"2005","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/16213194","citation_count":56,"is_preprint":false},{"pmid":"16807316","id":"PMC_16807316","title":"Promiscuous mismatch extension by human DNA polymerase lambda.","date":"2006","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/16807316","citation_count":39,"is_preprint":false},{"pmid":"12463744","id":"PMC_12463744","title":"Petasiphenol: a DNA polymerase lambda inhibitor.","date":"2002","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12463744","citation_count":38,"is_preprint":false},{"pmid":"18688254","id":"PMC_18688254","title":"Control of DNA polymerase lambda stability by phosphorylation and ubiquitination during the cell cycle.","date":"2008","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/18688254","citation_count":35,"is_preprint":false},{"pmid":"17686665","id":"PMC_17686665","title":"Human DNA polymerase lambda is a proficient extender of primer ends paired to 7,8-dihydro-8-oxoguanine.","date":"2007","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/17686665","citation_count":34,"is_preprint":false},{"pmid":"20435673","id":"PMC_20435673","title":"Loop 1 modulates the fidelity of DNA polymerase lambda.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20435673","citation_count":33,"is_preprint":false},{"pmid":"27481934","id":"PMC_27481934","title":"A fidelity mechanism in DNA polymerase lambda promotes error-free bypass of 8-oxo-dG.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/27481934","citation_count":30,"is_preprint":false},{"pmid":"16325764","id":"PMC_16325764","title":"Inhibitory effect of tocotrienol on eukaryotic DNA polymerase lambda and angiogenesis.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16325764","citation_count":30,"is_preprint":false},{"pmid":"30250067","id":"PMC_30250067","title":"PAXX and its paralogs synergistically direct DNA polymerase λ activity in DNA repair.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30250067","citation_count":26,"is_preprint":false},{"pmid":"15966901","id":"PMC_15966901","title":"DNA polymerase lambda directly binds to proliferating cell nuclear antigen through its confined C-terminal region.","date":"2005","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/15966901","citation_count":25,"is_preprint":false},{"pmid":"24171552","id":"PMC_24171552","title":"Expanding the scope of human DNA polymerase λ and β inhibitors.","date":"2013","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/24171552","citation_count":22,"is_preprint":false},{"pmid":"23330920","id":"PMC_23330920","title":"DNA polymerase λ inactivation by oxidized abasic sites.","date":"2013","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23330920","citation_count":19,"is_preprint":false},{"pmid":"20348107","id":"PMC_20348107","title":"Interaction between DNA Polymerase lambda and anticancer nucleoside analogs.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20348107","citation_count":18,"is_preprint":false},{"pmid":"22317757","id":"PMC_22317757","title":"Human DNA polymerase λ catalyzes lesion bypass across benzo[a]pyrene-derived DNA adduct during base excision repair.","date":"2012","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/22317757","citation_count":18,"is_preprint":false},{"pmid":"28841305","id":"PMC_28841305","title":"Living on the Edge: DNA Polymerase Lambda between Genome Stability and Mutagenesis.","date":"2017","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/28841305","citation_count":14,"is_preprint":false},{"pmid":"21486570","id":"PMC_21486570","title":"Ubiquitylation of DNA polymerase λ.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21486570","citation_count":13,"is_preprint":false},{"pmid":"30137433","id":"PMC_30137433","title":"Mutations induced by 8-oxo-7,8-dihydroguanine in WRN- and DNA polymerase λ-double knockdown cells.","date":"2018","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/30137433","citation_count":11,"is_preprint":false},{"pmid":"32224012","id":"PMC_32224012","title":"RanBP2-Mediated SUMOylation Promotes Human DNA Polymerase Lambda Nuclear Localization and DNA Repair.","date":"2020","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32224012","citation_count":10,"is_preprint":false},{"pmid":"26836966","id":"PMC_26836966","title":"Structural Mechanism for the Fidelity Modulation of DNA Polymerase λ.","date":"2016","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/26836966","citation_count":10,"is_preprint":false},{"pmid":"18976222","id":"PMC_18976222","title":"Interaction between DNA Polymerase lambda and RPA during translesion synthesis.","date":"2008","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/18976222","citation_count":8,"is_preprint":false},{"pmid":"38217735","id":"PMC_38217735","title":"The enzymatic properties of Arabidopsis thaliana DNA polymerase λ suggest a role in base excision repair.","date":"2024","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38217735","citation_count":6,"is_preprint":false},{"pmid":"28380295","id":"PMC_28380295","title":"Noncatalytic, N-terminal Domains of DNA Polymerase Lambda Affect Its Cellular Localization and DNA Damage Response.","date":"2017","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/28380295","citation_count":6,"is_preprint":false},{"pmid":"34119520","id":"PMC_34119520","title":"DNA polymerase λ promotes error-free replication through Watson-Crick impairing N1-methyl-deoxyadenosine adduct in conjunction with DNA polymerase ζ.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34119520","citation_count":6,"is_preprint":false},{"pmid":"25108835","id":"PMC_25108835","title":"N-terminal domains of human DNA polymerase lambda promote primer realignment during translesion DNA synthesis.","date":"2014","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/25108835","citation_count":5,"is_preprint":false},{"pmid":"33673424","id":"PMC_33673424","title":"A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33673424","citation_count":3,"is_preprint":false},{"pmid":"38428373","id":"PMC_38428373","title":"DNA polymerase λ Loop1 variant yields unexpected gain-of-function capabilities in nonhomologous end-joining.","date":"2024","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/38428373","citation_count":2,"is_preprint":false},{"pmid":"39000034","id":"PMC_39000034","title":"DNA Repair Protein XRCC1 Stimulates Activity of DNA Polymerase λ under Conditions of Microphase Separation.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39000034","citation_count":2,"is_preprint":false},{"pmid":"38093124","id":"PMC_38093124","title":"Non-Catalytic Domains of DNA Polymerase λ: Influence on Enzyme Activity and Its Regulation.","date":"2023","source":"Doklady. Biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/38093124","citation_count":1,"is_preprint":false},{"pmid":"24519361","id":"PMC_24519361","title":"Inhibition of DNA polymerase λ and associated inflammatory activities of extracts from steamed germinated soybeans.","date":"2014","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/24519361","citation_count":1,"is_preprint":false},{"pmid":"41875383","id":"PMC_41875383","title":"DNA repair under heat: DNA polymerase λ modulates heat stress-induced mutagenesis in plants.","date":"2026","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/41875383","citation_count":1,"is_preprint":false},{"pmid":"41700088","id":"PMC_41700088","title":"DNA polymerase λ autoinhibition is relieved via Ku interaction during non-homologous end joining.","date":"2026","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/41700088","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"sonnet_model":"claude-sonnet-4-6","sonnet_input_tokens":18059,"sonnet_output_tokens":7335,"sonnet_usd":0.1642,"sonnet_elapsed_seconds":136.0,"stage1_stop_reason":"end_turn"},"stage2":{"opus_model":"claude-opus-4-8","opus_input_tokens":16883,"opus_output_tokens":5770,"opus_usd":0.2287,"opus_elapsed_seconds":67.9,"stage2_stop_reason":"end_turn"},"total_usd":0.3929},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"Murine Pol lambda (POLL) displays intrinsic DNA polymerase activity when overproduced in E. coli, assessed by in situ gel analysis. It contains all critical residues for DNA binding, nucleotide binding, selection, and catalysis conserved in family X polymerases, including residues required for deoxyribose phosphate lyase (dRPase) activity. Its BRCT domain (first 230 aa) has no counterpart in Pol beta.\",\n      \"method\": \"In situ gel DNA polymerase activity assay; sequence analysis; Northern blotting and immunostaining for localization\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro activity demonstrated in E. coli overexpression system, single lab, single method for enzymatic activity\",\n      \"pmids\": [\"10966791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Human Pol lambda inserts nucleotides in a template-dependent manner and is processive on small gaps containing a 5'-phosphate group. It lacks proofreading activity and has ~37-fold higher affinity for dNTPs than Pol beta, consistent with function under low cellular dNTP levels. These properties support a role in base excision repair.\",\n      \"method\": \"Purification of recombinant human Pol lambda; biochemical polymerization and fidelity assays; nucleotide insertion kinetics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution with purified protein, multiple orthogonal assays (processivity, fidelity, dNTP affinity), single lab\",\n      \"pmids\": [\"11821417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pol lambda has intrinsic template-directed DNA polymerase activity requiring Mn2+ or Mg2+ as metal cofactors. The proline-rich region acts as a suppressor domain for its polymerization activity (SDPA). PCNA directly interacts with Pol lambda through its Pol beta-like region in vitro, and this interaction negatively regulates Pol lambda activity.\",\n      \"method\": \"Recombinant protein expression in E. coli; truncation mutants; chimeric enzyme construction; in vitro PCNA interaction assay\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro pulldown and activity assay with deletion constructs, multiple methods, single lab\",\n      \"pmids\": [\"12081642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Calf thymus-purified Pol lambda preferentially replicates damaged DNA and is aphidicolin-sensitive (unlike Pol beta). It has no detectable nuclease activity and is 6-fold more accurate than Pol beta in an M13mp2 forward mutation assay.\",\n      \"method\": \"Protein purification from calf thymus (5 chromatographic steps); polymerase activity assay on damaged and undamaged DNA; M13mp2 forward mutation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — biochemical characterization with purified native protein, single lab, single set of experiments\",\n      \"pmids\": [\"11886860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Crystal structure of human Pol lambda catalytic core in complex with a two-nucleotide gap DNA at 2.1 Å reveals limited contacts with template strand at the active site, a shift in DNA position reminiscent of a deletion intermediate, and the ability to adopt a closed conformation even without dNTP binding.\",\n      \"method\": \"X-ray crystallography (2.1 Å resolution); structural comparison with Pol beta ternary complex\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with functional implications, multiple structural comparisons, replicated by subsequent structural studies\",\n      \"pmids\": [\"14992725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pol lambda contributes to base excision repair (BER) as a backup to Pol beta. Using extracts from pol beta-/- and pol lambda-/- mouse embryonic fibroblasts combined with neutralizing antibodies, pol lambda antibody strongly reduced in vitro BER in pol beta-/- extracts, demonstrating pol lambda can substitute for pol beta in BER.\",\n      \"method\": \"Cell extract BER assay; pol lambda-/- and pol beta-/- mouse embryonic fibroblasts; neutralizing antibodies against pol lambda and pol beta\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic null cell lines combined with antibody neutralization, multiple genotypes tested, functional BER readout\",\n      \"pmids\": [\"15749700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pol lambda directly binds PCNA through a confined C-terminal region (residues 518–537), distinct from the canonical PIM motif. In vivo, Pol lambda co-immunoprecipitates with PCNA and EGFP-tagged Pol lambda co-localizes with PCNA as nuclear spots. PCNA binding suppresses the distributive nucleotidyltransferase activity of Pol lambda.\",\n      \"method\": \"Pull-down assay with deletion mutants; competitive peptide assay; co-immunoprecipitation; fluorescence microscopy (EGFP co-localization)\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal in vitro pulldown and in vivo co-IP, localization by fluorescence microscopy, functional consequence (activity suppression), multiple orthogonal methods\",\n      \"pmids\": [\"15966901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Pol lambda extends mismatched primer termini with ~10^-2 efficiency relative to matched pairs; efficiency is ~260-fold higher on 1-nt gapped molecules with 5'-phosphate versus open template-primer. A 2.4 Å crystal structure of Pol lambda with a dG:dGMP mismatch at the primer terminus shows Pol lambda cannot distinguish matched from mismatched termini during DNA binding, explaining its mismatch extension capacity relevant to NHEJ.\",\n      \"method\": \"In vitro mismatch extension kinetics; X-ray crystallography (2.4 Å) of mismatch-containing complex\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical kinetics combined with crystal structure, mechanistic explanation validated structurally, single lab\",\n      \"pmids\": [\"16807316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structures of Pol lambda at 1.9 Å (with non-hydrolyzable dUpnpp and Na+ at metal A site) and 2.0 Å (after soaking in MnCl2) reveal that Mn2+ occupying the metal A site induces a C3'-endo ribose conformation that positions the 3'-OH in-line with the alpha-phosphate, supporting a two-metal-ion catalytic mechanism. Catalysis in the crystal was directly observed upon MnCl2 soaking.\",\n      \"method\": \"X-ray crystallography (1.9 Å and 2.0 Å structures); crystal soaking experiments; structural comparison of pre- and post-catalytic states\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple high-resolution crystal structures including pre- and post-catalytic states, catalysis observed in crystal, mechanistic detail directly established\",\n      \"pmids\": [\"17475573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Pol lambda efficiently uses 8-oxoguanine (8-oxoG) as a template, inserting either dAMP or dCMP opposite it, but strongly discriminates against extension of the mutagenic 8-oxoG:dAMP pair while readily extending the non-mutagenic 8-oxoG:dCMP pair. Similar non-mutagenic extension was shown for O6-methylguanine.\",\n      \"method\": \"In vitro primer extension assay; kinetic analysis with purified human Pol lambda on 8-oxoG and m6G templates\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro biochemical assay with purified protein, single lab, no structural validation in this study\",\n      \"pmids\": [\"17686665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CDK2 phosphorylates Pol lambda in vitro. Phosphorylation of Thr553 is important for Pol lambda stability; a phosphorylation-defective T553 mutant is targeted for proteasomal degradation via ubiquitination. Pol lambda is stabilized during late S and G2 phases of the cell cycle, mimicking CDK2/cyclin A activity.\",\n      \"method\": \"In vitro kinase assay (CDK2); phosphorylation-defective mutant analysis; cell cycle synchronization; proteasome inhibitor experiments; Western blotting\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay plus in vivo mutant analysis and cell cycle experiments, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"18688254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RPA stimulates translesion DNA synthesis by Pol lambda in its globular conformation (not extended). This stimulation requires the p70N and p32C domains of RPA for protein-protein interactions.\",\n      \"method\": \"In vitro TLS assay with purified Pol lambda, RPA, and mutant hABCD RPA lacking protein-protein interaction domains; primer-template substrates with 8-oxoguanine\",\n      \"journal\": \"Biochemistry. Biokhimiia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vitro reconstitution with domain-deletion mutants of RPA, single lab, single method\",\n      \"pmids\": [\"18976222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MUTYH glycosylase and Pol lambda cooperate in a complete 8-oxo-G repair pathway. MUTYH, Pol lambda, PCNA, FEN1, and DNA ligases I and III are specifically recruited from human cell extracts to A:8-oxo-G DNA. The full repair pathway for A:8-oxo-G mispairs was reconstituted in vitro with purified MUTYH, Pol lambda, FEN1, and DNA ligase I.\",\n      \"method\": \"Immunofluorescence in ROS-exposed cells; in vitro DNA pulldown from cell extracts; full pathway reconstitution with purified proteins\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — full pathway reconstitution with purified proteins plus cell-based immunofluorescence validation, multiple orthogonal methods\",\n      \"pmids\": [\"19820168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Loop 1 of Pol lambda modulates fidelity by controlling dNTP-induced movements of the template strand and primer-terminal 3'-OH during the inactive-to-active conformation transition. Replacing 9 loop 1 residues with those from Pol beta did not affect catalytic efficiency for correct incorporation or NHEJ participation but significantly reduced accuracy in three biochemical fidelity assays.\",\n      \"method\": \"X-ray crystallography of loop 1 mutant (binary and ternary complexes); in vitro NHEJ assay; multiple fidelity assays; structural comparison\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures of mutant enzyme plus multiple biochemical fidelity assays, mechanistic model directly supported by structural data\",\n      \"pmids\": [\"20435673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structures show AraC and gemcitabine (dFdC) can bind within the nascent base pair binding pocket of Pol lambda. Pol lambda efficiently incorporates AraCTP but not dFdCTP, with the conformation of dFdCTP ribose being significantly different from normal dCTP.\",\n      \"method\": \"X-ray crystallography of Pol lambda bound to AraC or dFdC opposite template dG in gapped DNA; kinetic incorporation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures combined with biochemical incorporation assays, mechanistic explanation for differential incorporation\",\n      \"pmids\": [\"20348107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Pol lambda undergoes ubiquitylation as a post-translational modification that regulates its stability and possibly subcellular localization during the cell cycle.\",\n      \"method\": \"Review summarizing experimental evidence for Pol lambda ubiquitylation (referenced from primary experiments)\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — review paper summarizing prior findings without new primary data described in abstract\",\n      \"pmids\": [\"21486570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Pol lambda can perform gap-filling BER bypass of AP sites located at positions adjacent to (+)-cis-BPDE-dG adducts (but not trans-isomers), inserting correct dCTP. AP sites directly opposite cis-BP adducts can be repaired by Pol lambda but not Pol beta.\",\n      \"method\": \"In vitro primer extension and gap-filling assays with defined AP-site-containing oligonucleotide substrates bearing cis- or trans-BPDE-dG adducts; comparison of Pol lambda vs Pol beta\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro biochemical assay with purified proteins and defined substrates, single lab, single method\",\n      \"pmids\": [\"22317757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pol lambda is irreversibly inactivated by oxidized abasic lesions DOB and pC4-AP via covalent modification of active-site Lys324 (and potentially Lys312) in its lyase active site. Lyase inactivation also prevents polymerization. DOB inactivates Pol lambda ~3-fold less efficiently than Pol beta.\",\n      \"method\": \"Single-turnover kinetics; mass spectrometry of GluC-digested inactivated Pol lambda; defined lesion-containing DNA substrates\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — kinetics plus mass spectrometric identification of modified residues, direct mechanistic identification of inactivation sites\",\n      \"pmids\": [\"23330920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The BRCT domain of Pol lambda enhances abasic site bypass efficiency (~1.6-fold). The BRCT and proline-rich domains cooperatively promote -2 frameshift mutations through homology-driven primer realignment and increase -1 frameshift frequency during 8-oxodG bypass.\",\n      \"method\": \"Primer extension assays; high-throughput short oligonucleotide sequencing assay (HT-SOSA); N-terminal deletion constructs of Pol lambda\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple complementary biochemical assays with deletion constructs, two orthogonal sequencing approaches, single lab\",\n      \"pmids\": [\"25108835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Seven crystal structures and pre-steady-state kinetics characterize 8-oxo-dG bypass by Pol lambda. Pol lambda accommodates 8-oxo-dG in both anti and syn conformations; discrimination against the pro-mutagenic syn-conformation occurs at the extension step. A specific residue acts as a kinetic switch shunting repair toward long-patch BER upon correct dCMP insertion.\",\n      \"method\": \"X-ray crystallography (7 novel structures); pre-steady-state kinetics; mutagenesis to identify fidelity-determining residue\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple crystal structures combined with kinetics and mutagenesis, mechanistic detail fully characterized in single rigorous study\",\n      \"pmids\": [\"27481934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pol lambda apo-form exists in a closed conformation with a preformed MgdNTP binding pocket; a hydrophobic core (Leu431, Ile492, Tyr505/Phe506) attenuates MgdNTP prebinding to maintain medium fidelity. L431A mutation enhances MgdNTP prebinding and lowers fidelity. MgdNTP prebinding can stabilize mismatched and destabilize matched ternary complexes.\",\n      \"method\": \"X-ray crystallography (12 crystal structures); pre-steady-state kinetics; site-directed mutagenesis (L431A)\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — 12 crystal structures combined with kinetics and mutagenesis, multiple orthogonal methods in single study\",\n      \"pmids\": [\"26836966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The BRCT and proline/serine-rich (PSR) domains of Pol lambda impede its nuclear localization; the nuclear localization signal (NLS) is required to overcome this impediment. DNA damage induces Pol lambda recruitment to chromatin, controlled by the BRCT and PSR domains. Both domains are required for Pol lambda-mediated tolerance of oxidative but not methylation DNA damage.\",\n      \"method\": \"Western blot; fluorescence microscopy; cell survival assays; deletion constructs of BRCT, PSR, and NLS domains\",\n      \"journal\": \"Chemical research in toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell-based methods (imaging, fractionation, survival) with domain-deletion constructs, functional and localization readouts, single lab\",\n      \"pmids\": [\"28380295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PAXX, XLF, and XRCC4 share the ability to interact with Pol lambda, stimulate its activity, and are required for recruitment of Pol lambda to laser-induced DNA damage sites. Stimulation requires direct interaction between the SP/8 kDa domain of Pol lambda and the N-terminal head domains of XRCC4 paralogs to facilitate recognition of 5' end of substrate gaps. PAXX and XLF collaborate with Pol lambda for joining of incompatible DNA ends and are redundant in supporting Pol lambda function in vivo.\",\n      \"method\": \"Interactome analysis; direct interaction assays; Pol lambda activity stimulation assays; laser micro-irradiation and recruitment assays; in vivo NHEJ assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (interactome, direct binding, activity stimulation, live-cell recruitment, in vivo NHEJ), results replicated across three paralogs\",\n      \"pmids\": [\"30250067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Pol lambda is SUMOylated in vitro and in vivo, with Lys27 being the primary SUMO conjugation site. SUMOylation is mediated by the E3 ligase RanBP2 at the nuclear pore complex. This modification promotes Pol lambda nuclear entry, which is required for its recruitment to DNA lesions and is stimulated by DNA damage.\",\n      \"method\": \"In vitro SUMOylation assay; in vivo SUMOylation (co-IP); site-directed mutagenesis (K27); nuclear fractionation; immunofluorescence and damage recruitment assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro and in vivo SUMOylation with mutagenesis identifying modification site, identification of E3 ligase, functional consequence (nuclear entry/recruitment) with multiple methods\",\n      \"pmids\": [\"32224012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Pol lambda promotes error-free replication through N1-methyl-deoxyadenosine (1-MeA) by inserting the correct nucleotide T opposite 1-MeA, likely via Hoogsteen base pairing with 1-MeA in a syn conformation. Pol lambda acts as the insertion polymerase in a Pol lambda/Pol zeta-dependent TLS pathway for 1-MeA bypass.\",\n      \"method\": \"Biochemical TLS assay with purified Pol lambda; genetic analysis in human cells (siRNA knockdown); epistasis with Pol zeta\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical insertion assay with purified polymerase combined with genetic epistasis in human cells, single lab\",\n      \"pmids\": [\"34119520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Pol lambda promotes annealing of G-rich telomeric repeats to complementary strands and can prime DNA synthesis on these substrates. POT1/TPP1 heterodimer stimulates this activity, while TERRA RNA and RPA negatively regulate it. Pol lambda associates with telomeres and co-localizes with TPP1 in cells, and its silencing represses ALT activity and induces telomeric stress.\",\n      \"method\": \"Annealing and primer extension assays with purified proteins; co-immunoprecipitation/ChIP for telomere association; immunofluorescence co-localization; siRNA knockdown with ALT activity readout\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro biochemical reconstitution plus cell-based co-localization and knockdown, multiple methods, single lab\",\n      \"pmids\": [\"33673424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The non-catalytic N-terminal region of Pol lambda (BRCT and proline-rich domains) suppresses both its polymerase activity and its interactions with DNA and with PARP1. RPA interaction with Pol lambda is also modulated by these non-catalytic domains.\",\n      \"method\": \"In vitro polymerase activity assays; protein-protein interaction assays (Pol lambda with PARP1 and RPA); N-terminal deletion constructs\",\n      \"journal\": \"Doklady. Biochemistry and biophysics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — in vitro assays with deletion constructs, single lab, single paper, limited detail in abstract\",\n      \"pmids\": [\"38093124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A Pol lambda loop 1 variant (PolλKGET) retains canonical Pol lambda activity on paired DNA ends but acquires the ability to synthesize from unpaired primer termini—activity normally unique to Pol mu. The Loop1 amino acid sequence is essential for this gained activity during NHEJ despite making no direct contact with DNA substrate.\",\n      \"method\": \"In vitro NHEJ assay; primer extension on paired and unpaired substrates; structural prediction\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical NHEJ and extension assays with defined mutant, multiple substrate types tested, single lab\",\n      \"pmids\": [\"38428373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"XRCC1 stimulates the gap-filling activity of Pol lambda under conditions of microphase separation. XRCC1 forms protein-rich microphases with DNA, and Pol lambda, XRCC1, and gapped DNA co-localize within these microphases. Stimulation occurs at micromolar XRCC1 concentrations and requires both protein-protein interaction and microphase separation conditions.\",\n      \"method\": \"In vitro gap-filling assay; dynamic light scattering; fluorescence microscopy for co-localization in microphases; binding affinity measurement for XRCC1-Pol lambda complex\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro reconstitution plus biophysical characterization (DLS, fluorescence microscopy), multiple orthogonal methods, single lab\",\n      \"pmids\": [\"39000034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Pol lambda possesses an autoinhibitory intramolecular interaction between its N-terminal BRCT domain and C-terminal catalytic domain. Ku binding to the KBM within the BRCT domain relieves this autoinhibition, increasing both Pol lambda binding rate to primer-template DNA and nucleotide incorporation rate. Single-molecule assays demonstrate Ku stimulates Pol lambda polymerase activity at DSBs within the short-range synaptic complex during NHEJ.\",\n      \"method\": \"Structural prediction; biochemical activity assays; single-molecule approaches; KBM mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — structural prediction validated by biochemical assays and single-molecule experiments with mutagenesis, multiple orthogonal methods establishing autoinhibition mechanism\",\n      \"pmids\": [\"41700088\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DNA polymerase lambda (POLL) is a family X DNA repair polymerase that fills short gaps during base excision repair (BER) and non-homologous end joining (NHEJ) of double-strand breaks via a two-metal-ion phosphoryl transfer mechanism; its activity is regulated by an autoinhibitory BRCT-catalytic domain interaction relieved by Ku binding, by CDK2-mediated phosphorylation of Thr553 (protecting it from ubiquitin-proteasomal degradation), by RanBP2-mediated SUMOylation at Lys27 (promoting nuclear import), by direct interaction with PCNA (via residues 518–537, suppressing distributive activity), and by stimulation from XRCC4 paralogs (PAXX, XLF, XRCC4) through their head domains binding the SP/8 kDa domain of Pol lambda; its medium fidelity is mechanistically enforced by a hydrophobic core attenuating MgdNTP prebinding and by Loop 1 controlling template strand positioning, while its unique BRCT and proline-rich N-terminal domains modulate nuclear localization, damage recruitment, primer realignment, and selective tolerance of oxidative DNA damage.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DNA polymerase lambda (POLL) is a family X DNA repair polymerase that fills short DNA gaps during base excision repair (BER) and non-homologous end joining (NHEJ), using a two-metal-ion phosphoryl transfer mechanism in which Mn2+/Mg2+ at the metal A site positions the primer 3'-OH in-line with the alpha-phosphate for catalysis [#8]. It is template-dependent, lacks proofreading, is processive on small 5'-phosphate-containing gaps, and has high dNTP affinity consistent with function at low cellular dNTP levels [#1]. Pol lambda serves as a backup to Pol beta in BER, substituting for it in cell-extract repair [#5], and it cooperates with the MUTYH glycosylase, PCNA, FEN1, and DNA ligases in a reconstituted pathway that repairs A:8-oxo-G mispairs [#12]. Its medium fidelity is mechanistically enforced by a closed apo-conformation with a preformed MgdNTP pocket whose hydrophobic core attenuates MgdNTP prebinding [#20] and by Loop 1, which controls dNTP-induced template-strand and primer-terminus movements [#13]; structural studies further show it accommodates 8-oxo-dG in anti and syn forms and discriminates against the mutagenic pairing at the extension step [#19]. In NHEJ, Pol lambda extends mismatched and partially paired ends [#7], is stimulated and recruited to damage by the XRCC4 paralogs PAXX, XLF, and XRCC4 binding its SP/8 kDa domain [#22], and its catalytic activity is relieved from an autoinhibitory BRCT–catalytic domain interaction by Ku binding within the short-range synaptic complex [#29]. Its non-catalytic BRCT and proline-rich N-terminal domains suppress polymerase activity and DNA/partner interactions, govern nuclear localization and chromatin recruitment, and confer selective tolerance of oxidative damage [#21, #26]. Pol lambda activity is post-translationally tuned by CDK2 phosphorylation of Thr553, which protects it from ubiquitin-proteasomal degradation across the cell cycle [#10], and by RanBP2-mediated SUMOylation at Lys27, which promotes nuclear entry and damage recruitment [#23].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that POLL encodes an intrinsically active DNA polymerase of the family X repair class, distinguished from Pol beta by an additional BRCT domain.\",\n      \"evidence\": \"In situ gel polymerase activity assay of murine Pol lambda overexpressed in E. coli with sequence analysis\",\n      \"pmids\": [\"10966791\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Activity shown only in an overexpression system\", \"No defined repair substrate or cellular pathway assigned\", \"dRPase activity inferred from conserved residues, not measured\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined the enzymatic profile pointing to BER: template-dependent, processive on 5'-phosphate gaps, no proofreading, and high dNTP affinity, while identifying PCNA as a negative regulator acting through the proline-rich suppressor domain.\",\n      \"evidence\": \"Biochemical assays with purified recombinant human Pol lambda; truncation mutants and in vitro PCNA interaction; calf-thymus native protein characterization\",\n      \"pmids\": [\"11821417\", \"12081642\", \"11886860\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"BER role inferred from biochemistry, not yet genetically demonstrated\", \"Physiological relevance of PCNA suppression untested in cells\", \"Damaged-template preference not mechanistically explained\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Provided the structural basis for gap-filling, showing limited template contacts and a DNA shift resembling a deletion intermediate, foreshadowing frameshift propensity.\",\n      \"evidence\": \"2.1 Å crystal structure of the catalytic core on two-nucleotide gap DNA, compared to Pol beta\",\n      \"pmids\": [\"14992725\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic chemistry not yet captured\", \"Role of N-terminal domains not addressed by core structure\", \"Functional consequence of deletion-like intermediate not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated genetically that Pol lambda substitutes for Pol beta in BER and mapped a non-canonical PCNA-binding region controlling distributive activity.\",\n      \"evidence\": \"Cell-extract BER assays in pol beta-/- and pol lambda-/- MEFs with neutralizing antibodies; reciprocal pulldown, co-IP, and EGFP co-localization for PCNA\",\n      \"pmids\": [\"15749700\", \"15966901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative in vivo contribution of Pol lambda vs Pol beta unquantified\", \"Conditions selecting Pol lambda over Pol beta unclear\", \"PCNA recruitment dynamics at lesions not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved the two-metal-ion catalytic mechanism and connected Pol lambda to oxidative-damage processing by showing non-mutagenic extension of 8-oxoG:dCMP.\",\n      \"evidence\": \"1.9/2.0 Å crystal structures with catalysis observed upon MnCl2 soaking; primer-extension kinetics on 8-oxoG and m6G templates\",\n      \"pmids\": [\"17475573\", \"17686665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of syn/anti 8-oxoG discrimination not yet resolved\", \"In vivo relevance of damage-tolerant extension untested\", \"Metal selectivity (Mn vs Mg) physiology unaddressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified cell-cycle-coupled stability control, showing CDK2 phosphorylation of Thr553 protects Pol lambda from ubiquitin-proteasomal degradation, and partner-mediated TLS stimulation by RPA.\",\n      \"evidence\": \"In vitro CDK2 kinase assay, phospho-defective mutant, cell-cycle synchronization and proteasome inhibition; in vitro TLS reconstitution with RPA domain-deletion mutants\",\n      \"pmids\": [\"18688254\", \"18976222\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase targeting Pol lambda not identified\", \"Functional output of S/G2 stabilization not linked to a repair event\", \"RPA stimulation mechanism not structurally defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Placed Pol lambda within a complete reconstituted pathway for repair of A:8-oxo-G mispairs, defining its functional partners in oxidative-damage repair.\",\n      \"evidence\": \"Immunofluorescence in ROS-exposed cells, DNA pulldown from extracts, and full reconstitution with purified MUTYH, Pol lambda, FEN1, and DNA ligase I\",\n      \"pmids\": [\"19820168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order and regulation of factor handoff not defined\", \"Direct Pol lambda–MUTYH interaction surface unmapped\", \"Contribution relative to other polymerases in vivo unquantified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined structural determinants of fidelity (Loop 1 controlling template/primer movement) and the active-site recognition of nucleoside-analog drugs.\",\n      \"evidence\": \"Crystal structures of loop 1 mutant with NHEJ and fidelity assays; structures of AraC/gemcitabine bound in the nascent base-pair pocket with kinetics\",\n      \"pmids\": [\"20435673\", \"20348107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Loop 1 contribution to in vivo mutagenesis not measured\", \"Therapeutic relevance of analog incorporation untested in cells\", \"Interplay of Loop 1 with N-terminal domains unaddressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established a mechanism of irreversible lyase-driven self-inactivation by oxidized abasic lesions through covalent modification of active-site lysines.\",\n      \"evidence\": \"Single-turnover kinetics and mass spectrometry of GluC-digested inactivated Pol lambda with defined DOB/pC4-AP substrates\",\n      \"pmids\": [\"23330920\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequences of this suicide inactivation not demonstrated\", \"Whether inactivation occurs at physiological lesion levels unknown\", \"Relationship to Pol beta inactivation in shared lesions not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Assigned functions to the non-catalytic N-terminal domains, showing BRCT and proline-rich regions drive homology-mediated primer realignment and frameshift mutagenesis.\",\n      \"evidence\": \"Primer extension and HT-SOSA sequencing with N-terminal deletion constructs on abasic and 8-oxodG substrates\",\n      \"pmids\": [\"25108835\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo frameshift signature not established\", \"Structural basis of realignment by N-terminal domains unresolved\", \"Single-lab biochemical observation\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Provided a unified structural-kinetic model of medium fidelity, defining 8-oxoG handling at the extension step and a hydrophobic core that attenuates MgdNTP prebinding.\",\n      \"evidence\": \"Multiple crystal structures (7 and 12) with pre-steady-state kinetics and mutagenesis (L431A, kinetic-switch residue)\",\n      \"pmids\": [\"27481934\", \"26836966\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular fidelity consequences of core mutations untested\", \"Long-patch vs short-patch BER routing in vivo unconfirmed\", \"Generalizability of prebinding model to all substrates unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed that the BRCT and proline/serine-rich domains restrain nuclear import and govern damage-induced chromatin recruitment, conferring selective tolerance of oxidative damage.\",\n      \"evidence\": \"Fluorescence microscopy, fractionation, and survival assays with BRCT/PSR/NLS deletion constructs\",\n      \"pmids\": [\"28380295\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular signal triggering recruitment unidentified\", \"Mechanism distinguishing oxidative vs methylation tolerance unclear\", \"Single-lab cell-based study\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified the XRCC4-paralog interface, showing PAXX, XLF, and XRCC4 bind the SP/8 kDa domain to stimulate activity and recruit Pol lambda to DSBs for joining of incompatible ends.\",\n      \"evidence\": \"Interactome, direct binding, activity stimulation, laser micro-irradiation recruitment, and in vivo NHEJ assays across three paralogs\",\n      \"pmids\": [\"30250067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural detail of the SP/8 kDa–head domain interface not solved\", \"Hierarchy among the three paralogs in vivo not fully resolved\", \"Integration with core NHEJ machinery timing unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined a SUMO-dependent nuclear import route, with RanBP2 SUMOylating Lys27 at the nuclear pore to enable damage recruitment.\",\n      \"evidence\": \"In vitro and in vivo SUMOylation, K27 mutagenesis, nuclear fractionation, and damage-recruitment imaging\",\n      \"pmids\": [\"32224012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between SUMOylation and BRCT/PSR import restraint unresolved\", \"Whether SUMOylation is damage-inducible at the modification step unclear\", \"deSUMOylation/reversal not characterized\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended Pol lambda's repertoire to error-free TLS of 1-MeA and to telomere maintenance, including a role in ALT activity.\",\n      \"evidence\": \"Biochemical TLS with epistasis to Pol zeta in human cells; annealing/extension assays with POT1/TPP1, TERRA, RPA regulation and telomere co-localization/knockdown\",\n      \"pmids\": [\"34119520\", \"33673424\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo significance of telomeric role beyond ALT cells unknown\", \"Structural basis of 1-MeA Hoogsteen bypass not solved\", \"Single-lab observations for each role\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed that microenvironment and Loop 1 sequence tune Pol lambda's end-joining behavior: XRCC1 microphase separation stimulates gap filling, and a Loop 1 variant gains Pol mu-like unpaired-primer synthesis.\",\n      \"evidence\": \"In vitro gap-filling with DLS and microscopy of XRCC1 microphases; NHEJ and paired/unpaired primer-extension assays with the PolλKGET Loop 1 variant\",\n      \"pmids\": [\"39000034\", \"38428373\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological occurrence of microphase separation unverified\", \"How Loop 1 confers activity without DNA contact unexplained\", \"In vivo relevance of engineered Loop 1 variant unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Resolved the principal autoregulatory switch, demonstrating an intramolecular BRCT–catalytic autoinhibition relieved by Ku binding to activate Pol lambda within the NHEJ synaptic complex.\",\n      \"evidence\": \"Structural prediction with biochemical activity and single-molecule assays and KBM mutagenesis\",\n      \"pmids\": [\"41700088\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure of the autoinhibited state not determined\", \"Coordination of Ku relief with XRCC4-paralog and PTM regulation unresolved\", \"Whether the same switch operates in BER unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple regulatory layers—N-terminal autoinhibition, Ku/XRCC4-paralog stimulation, PCNA/RPA/PARP1/XRCC1 modulation, and CDK2/SUMO post-translational control—are integrated to select Pol lambda for BER versus NHEJ versus telomere maintenance in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified in vivo model coordinating the regulatory inputs\", \"Quantitative pathway partitioning of Pol lambda not established\", \"No disease association mapped within the available corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 1, 4, 8]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 8, 19]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 7, 20]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 21, 23]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [5, 12, 22, 29]}\n    ],\n    \"complexes\": [\"NHEJ short-range synaptic complex\"],\n    \"partners\": [\"PCNA\", \"XRCC4\", \"XLF\", \"PAXX\", \"Ku\", \"RPA\", \"XRCC1\", \"MUTYH\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win"}}